<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03842813</url>
  </required_header>
  <id_info>
    <org_study_id>2018-A02663-52</org_study_id>
    <nct_id>NCT03842813</nct_id>
  </id_info>
  <brief_title>Safety and Performance Assessment of Drug-Eluting Stent CRE8 in Diabetic Patients</brief_title>
  <acronym>EVALU8</acronym>
  <official_title>Safety and Performance Assessment of Coronary Drug-Eluting Stent CRE8 : Post-market Observationnal Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Alvimedica Medical Technologies France</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>EVAMED</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Alvimedica Medical Technologies France</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study is a 'real-world' study which evaluates the safety and performance of the coronary
      DES-CRE8 in diabetic patients.

      As routine care, each patient will be followed until 12 months after stent implantation.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 9, 2019</start_date>
  <completion_date type="Anticipated">March 2021</completion_date>
  <primary_completion_date type="Anticipated">March 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>The primary endpoint is Target Lesion Failure (TLF) rate at 1 year</measure>
    <time_frame>1 year post implantation</time_frame>
    <description>The TLF is defined as cardiac deaths, heart attack in relation with the target vessel or revascularization of the target lesion.
If a patient has at least one of these events, he will be considered as TLF.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Major Adverse Cardiac Events (MACE) at 1 year</measure>
    <time_frame>1 year</time_frame>
    <description>MACE are defined as: revascularization of the target lesion, heart attack or cardiac deaths.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Non cardiac deaths at 1 year</measure>
    <time_frame>1 year</time_frame>
    <description>Non cardiac deaths at 1 year</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Stent thrombosis at 1 year</measure>
    <time_frame>1 year</time_frame>
    <description>Certain or probable stent thrombosis</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Major Adverse Cardiac Events (MACE) at 1 year in the sub-group of patients with a short planned dual-therapy</measure>
    <time_frame>1 year</time_frame>
    <description>MACE are defined as: revascularization of the target lesion, heart attack or cardiac deaths.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Non cardiac deaths at 1 year in the sub-group of patients with a short planned dual-therapy</measure>
    <time_frame>1 year</time_frame>
    <description>Non cardiac deaths at 1 year</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Stent thrombosis at 1 year in the sub-group of patients with a short planned dual-therapy</measure>
    <time_frame>1 year</time_frame>
    <description>Certain or probable stent thrombosis</description>
  </secondary_outcome>
  <enrollment type="Anticipated">1200</enrollment>
  <condition>Diabetes</condition>
  <condition>Coronaropathy</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>DES-CRE8</intervention_name>
    <description>Polymer-free Amphilimus™ (Sirolimus + Fatty Acid) eluting coronary stent. The absence of the polymer minimizes the risk of inflammation/thrombosis, while the propriety formulation enhances drug absorption.</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Participation to the study will be proposed to all diabetic patients corresponding to the
        inclusion and exclusion criteria after implantation of one or more coronary stent CRE8.

        Patients will be consecutively included to limit selection bias.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  ≥18 years old,

          -  patient informed and agreed to participate,

          -  patient with one or more lesions treated with one or more coronary stent CRE8,

          -  patient with a diabete insulin dependent or non-insulin dependant.

        Exclusion Criteria:

          -  pregnant or breast-feading women,

          -  patient who refused to participate,

          -  patient with another lesion treated during the same intervention with a balloon alone
             or with another stent
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Julien Vandenwildenberg</last_name>
    <role>Study Chair</role>
    <affiliation>Alvimedica Medical France</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Anne-Claire Thieulin</last_name>
    <phone>+33 2 31 93 21 18</phone>
    <email>anne-claire.thieulin@evamed.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Clinique de l'Europe</name>
      <address>
        <city>Amiens</city>
        <zip>80090</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Rafik Lamari</last_name>
    </contact>
    <investigator>
      <last_name>Antoine Py, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier Avignon</name>
      <address>
        <city>Avignon</city>
        <zip>84902</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>José Sevilla</last_name>
    </contact>
    <investigator>
      <last_name>Michel Pansieri, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier Beauvais</name>
      <address>
        <city>Beauvais</city>
        <zip>60000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Fabienne Huysman</last_name>
    </contact>
    <investigator>
      <last_name>Anne Luycx-Bore, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Clinique Convert</name>
      <address>
        <city>Bourg-en-Bresse</city>
        <zip>01004</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Nicolas Eydoux</last_name>
    </contact>
    <investigator>
      <last_name>Robin, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier Brive</name>
      <address>
        <city>Brive-la-Gaillarde</city>
        <zip>19100</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Sébastien Bosle</last_name>
    </contact>
    <investigator>
      <last_name>Sébastien Bosle, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier Chartres</name>
      <address>
        <city>Chartres</city>
        <zip>280018</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Christophe Laure</last_name>
    </contact>
    <investigator>
      <last_name>Grégoire Rangé, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hôpital Schweitzer</name>
      <address>
        <city>Colmar</city>
        <zip>68003</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Hervé Faltot</last_name>
    </contact>
    <investigator>
      <last_name>Philoktimon Plastaras, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier Sud-Francilien</name>
      <address>
        <city>Corbeil-Essonnes</city>
        <zip>91106</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Romain Berthier, Dr</last_name>
    </contact>
    <investigator>
      <last_name>Romain Berthier, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hôpital Privé de Bourgogne</name>
      <address>
        <city>Dijon</city>
        <zip>21000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Edda Calabro</last_name>
    </contact>
    <investigator>
      <last_name>Philippe Brunel, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hôpital Simone Veil</name>
      <address>
        <city>Eaubonne</city>
        <zip>95602</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Gaëtan Karillon, Dr</last_name>
    </contact>
    <investigator>
      <last_name>Gaëtan Karillon, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Clinique Pasteur</name>
      <address>
        <city>Essey-lès-Nancy</city>
        <zip>54270</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Jean-Philippe Simon, Dr</last_name>
    </contact>
    <investigator>
      <last_name>Jean-Philippe Simon, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier Gonesse</name>
      <address>
        <city>Gonesse</city>
        <zip>95500</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Pierre Aubry, Dr</last_name>
    </contact>
    <investigator>
      <last_name>Pierre Aubry, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier Universitaire Grenoble</name>
      <address>
        <city>Grenoble</city>
        <zip>38043</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Clémence Charlon</last_name>
    </contact>
    <investigator>
      <last_name>Gilles Barone, Pr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier Haguenau</name>
      <address>
        <city>Haguenau</city>
        <zip>67500</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Jean-Marc Daesslé</last_name>
    </contact>
    <investigator>
      <last_name>Fabien De Poli, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier Saint-Joseph Saint-Luc</name>
      <address>
        <city>Lyon</city>
        <zip>69365</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Clinique Pont de Chaumes</name>
      <address>
        <city>Montauban</city>
        <zip>82000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Angélique Andrieu</last_name>
    </contact>
    <investigator>
      <last_name>Axel De Labriolle, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier Pau</name>
      <address>
        <city>Pau</city>
        <zip>64000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Nicolas Delarche, Dr</last_name>
    </contact>
    <investigator>
      <last_name>Nicolas Delarche, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Clinique Saint-Hilaire</name>
      <address>
        <city>Rouen</city>
        <zip>76000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Françoise Hupel</last_name>
    </contact>
    <investigator>
      <last_name>Godin, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier Saint-Quentin</name>
      <address>
        <city>Saint-Quentin</city>
        <zip>02321</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Florent Chevalier, Dr</last_name>
    </contact>
    <investigator>
      <last_name>Florent Chevalier, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Clinique Saint-Joseph</name>
      <address>
        <city>Trélazé</city>
        <zip>49800</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Julien Jeanneteau, Dr</last_name>
    </contact>
    <investigator>
      <last_name>Julien Jeanneteau, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier Valence</name>
      <address>
        <city>Valence</city>
        <zip>26000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Karine Combe</last_name>
    </contact>
    <investigator>
      <last_name>Stanislas Champin, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier Vannes</name>
      <address>
        <city>Vannes</city>
        <zip>56017</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Alain Kermarrec, Dr</last_name>
    </contact>
    <investigator>
      <last_name>Alain Kermarrec, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>April 2019</verification_date>
  <study_first_submitted>February 11, 2019</study_first_submitted>
  <study_first_submitted_qc>February 13, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">February 15, 2019</study_first_posted>
  <last_update_submitted>April 12, 2019</last_update_submitted>
  <last_update_submitted_qc>April 12, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">April 16, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

